What Payers Will Demand From Evidence in 2026

The start of a new year brings more than refreshed planning cycles, it brings a reset in payer expectations. As 2026 gets underway, payers are signaling that the evidence bar is rising. Traditional endpoints alone are no longer sufficient. Retrospective analyses...

AI & Predictive Modeling Are Transforming HEOR

For years, HEOR teams have focused on describing the past: analyzing retrospective claims, EMR data, and trial endpoints to understand treatment patterns and cost trajectories. But the next competitive edge in market access won’t come from explaining what happened. It...

Preparing for 2026: 5 Priorities for Market Access Leaders

2026 isn’t far off. Are your access priorities ready for the next wave of IRA-driven disruption? Between Inflation Reduction Act (IRA) implementation milestones, global pricing pressures, and payer adoption of new contracting models, the next 18 months will redefine...